GE HealthCare Exceeds Q4 & FY25 Expectations, Issues Strong 2026 Guidance
GEHC sits 40% above its 52-week low of $57.65.
Summary
GE HealthCare reported Q4 and full-year 2025 results exceeding expectations and provided strong 2026 guidance, projecting continued growth and margin expansion.
Key Events · Earnings and Guidance · GEHC
-
Exceeded Q4 & FY25 Expectations
The company reported Q4 2025 revenue of $5.7 billion (up 7.1%, 4.8% organic) and Adjusted EPS of $1.44, exceeding market expectations. Full-year 2025 revenue reached $20.6 billion (up 4.8%, 3.5% organic) with Adjusted EPS of $4.59, also surpassing forecasts.
-
Strong 2026 Guidance Issued
GE HealthCare introduced 2026 full-year guidance, projecting organic revenue growth of 3.0% to 4.0%, Adjusted EBIT margin expansion of 50 to 80 basis points (15.8% to 16.1%), and Adjusted EPS in the range of $4.95 to $5.15, representing 7.9% to 12.3% growth year-over-year.
-
Strategic Capital Deployment
The company executed $200 million in share repurchases during 2025 under a $1.0 billion authorized program. Additionally, it announced the planned $2.3 billion acquisition of Intelerad, expected to close in the first half of 2026, to advance cloud-enabled enterprise imaging.
-
Operational Resilience and Cash Flow
Despite negative impacts from tariff expense and unfavorable mix on margins, the company demonstrated operational resilience. It generated $916 million in Free Cash Flow for Q4 2025 and $1.5 billion for the full year, supporting growth ambitions and capital returns.
Analysis · GEHC · Industrial Applications And Services
GE HealthCare Technologies Inc. reported strong fourth quarter and full-year 2025 financial results, surpassing both top-line and earnings per share expectations. The company demonstrated operational resilience despite tariff impacts, achieving robust organic revenue growth across key segments. The introduction of optimistic 2026 guidance, projecting continued organic revenue growth, Adjusted EBIT margin expansion, and significant Adjusted EPS growth, signals confidence in future performance. Strategic capital deployment, including a share repurchase program and a planned $2.3 billion acquisition, further underscores the company's commitment to enhancing shareholder value and expanding its cloud-enabled enterprise imaging capabilities.
At the time of this filing, GEHC was trading at $80.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.9B. The 52-week trading range was $57.65 to $94.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.